Read + Share
Mei J, Jiang G, Chen Y, Xu Y, et al. HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the
therapeutic response to anti-PD-1 immunotherapy in NSCLC. BMC Cancer 2022;22:738.
PMID: 35794593
|
 |
|
Mei J, Jiang G, Chen Y, Xu Y, et al. HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the
therapeutic response to anti-PD-1 immunotherapy in NSCLC. BMC Cancer 2022;22:738.
PMID: 35794593
|
|
|
|